Phase II pilot study of bortezomib (Velcade) and gemcitabine for patients with relapsed or refractory Hodgkin's lymphoma
Phase of Trial: Phase II
Latest Information Update: 11 May 2016
At a glance
- Drugs Bortezomib (Primary) ; Gemcitabine (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 17 Jul 2007 Status changed from recruiting to in progress.
- 16 Aug 2006 New trial record.